Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
The University of Sheffield maintains a portfolio in the Biotechnology & Pharmaceuticals technology area. There are currently 5 pending office actions associated with this entity. These actions are spread across 5 distinct examiners and 5 distinct art units. This distribution suggests that the university's research in biotechnology and pharmaceuticals covers 5 technical classifications within the patent office.
DIAS, RAVEEN J is the busiest examiner for the university, currently overseeing 1 pending office action. Because there are 5 pending office actions and 5 distinct examiners, the workload is distributed with each examiner handling 1 action. This 1 to 1 ratio between examiners and pending actions means that the prosecution strategy involves 5 different individual perspectives. The presence of 5 distinct art units reinforces the observation that the university's intellectual property is being evaluated by 5 groups within the USPTO. This environment requires managing interactions across 5 distinct administrative units simultaneously.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §112 only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DIAS, RAVEEN J | 1 | 80.7% | +17.3% |
| BENAVIDES, JENNIFER ANN | 1 | 51.2% | +47.0% |
| NGUYEN, NAM P | 1 | 54.8% | +48.7% |
| BOSWORTH, KAMI A | 1 | 69.1% | +28.7% |
| ADLAM, CHANTAL PETA-GAYE | 1 | 53.5% | +27.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17779872 | GUIDING DEVICE FOR A VASCULAR CATHETER | BOSWORTH, KAMI A | 29d overdue |
| 18521941 | SPOOL TENSION COUPLING, SYSTEM AND METHOD | DIAS, RAVEEN J | — |
| 18271980 | METHODS OF PREDICTING PROGRESSION OF NEUROLOGICAL DISEASE | NGUYEN, NAM P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17286797 | TREATMENT OF NEUROLOGICAL DISEASE | ADLAM, CHANTAL PETA-GAYE | 49d overdue |
| 17779872 | GUIDING DEVICE FOR A VASCULAR CATHETER | BOSWORTH, KAMI A | 29d overdue |
| 18521941 | SPOOL TENSION COUPLING, SYSTEM AND METHOD | DIAS, RAVEEN J | — |
| 18286040 | PERIVASCULAR ACCUMULATION OF IMMUNE CELLS IN THE DIAGNOSIS AND TREATMENT OF CANCER | BENAVIDES, JENNIFER ANN | — |
| 18271980 | METHODS OF PREDICTING PROGRESSION OF NEUROLOGICAL DISEASE | NGUYEN, NAM P | — |
| Art Unit | Apps |
|---|---|
| 3654 | 1 |
| 1675 | 1 |
| 1678 | 1 |
| 3783 | 1 |
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18521941 | SPOOL TENSION COUPLING, SYSTEM AND METHOD | DIAS, RAVEEN J | 3654 | §102§103 | Non-Final OA | — | Pending | Nov 28, 2023 |
| 18286040 | PERIVASCULAR ACCUMULATION OF IMMUNE CELLS IN THE DIAGNOSIS AND TREATMENT OF CANCER | BENAVIDES, JENNIFER ANN | 1675 | §112Other | Non-Final OA | — | Pending | Oct 06, 2023 |
| 18271980 | METHODS OF PREDICTING PROGRESSION OF NEUROLOGICAL DISEASE | NGUYEN, NAM P | 1678 | §101§102§103§112 | Non-Final OA | — | Pending | Jul 12, 2023 |
| 17779872 | GUIDING DEVICE FOR A VASCULAR CATHETER | BOSWORTH, KAMI A | 3783 | §102§103 | Non-Final OA | 29d overdue | Pending | May 25, 2022 |
| 17286797 | TREATMENT OF NEUROLOGICAL DISEASE | ADLAM, CHANTAL PETA-GAYE | 1622 | §103DP | Final Rejection | 49d overdue | Pending | Apr 19, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial